In vitro experiments have shown that addition of YKL-40 protein to cells of connective tissue resulted in increased cell proliferation through AKT activation and MAPK pathways, nominating YKL-40 as a potential regulator of these signaling pathways, since its secreted form is the product of one of the most expressed genes in glioblastoma with prognostic potential for these tumors [22]. The gene discussed is AKT1; the disease is glioblastoma.